首頁 > 市場調查報告書 > 製藥

生物製劑分子標靶治療學

市場調查報告書

商品編碼

2084623

用於癌症和非癌症診斷的單株抗體市場：按抗體類型、所用技術、應用、最終用戶、分銷管道和地區分類

Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, By Usage Techniques, By Application, By End User, By Distribution Channel, By Geography

出版日期: 2026年06月26日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

用於癌症和非癌症診斷的單株抗體市場預計在 2026 年達到 101.293 億美元，預計到 2033 年將達到 182.912 億美元。預計從 2026 年到 2033 年，該市場將以 8.8% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	101.293億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.80%	2033年市場規模預測：	182.912億美元

全球單株抗體市場涵蓋了癌症和非癌症診斷領域，其中包括多種基於單株抗體的診斷產品。這些基於抗體的診斷方法用於檢測、鑑別和管理各種臨床適應症的多種疾病，包括腫瘤、感染疾病、自體免疫疾病和心血管疾病。由於其高特異性和高靈敏度，單株抗體被廣泛應用於多種高通量檢測技術，例如免疫組織化學 (IHC)、酵素免疫分析法(ELISA)、流式細胞技術和伴隨診斷。

癌症發生率上升、伴隨診斷需求增加以及病理學和分子診斷平台技術的進步是推動市場擴張的主要因素。單株抗體在感染疾病診斷、自體免疫疾病管理和個人化治療方案等領域的應用不斷拓展，將繼續推動其普及，鞏固其作為醫院、診斷檢查室和研究機構關鍵診斷工具的地位。

市場動態

全球單株抗體市場對癌症和非癌症診斷的需求成長主要受以下因素驅動：包括癌症、自體免疫疾病和感染疾病的慢性疾病數量不斷增加，這些疾病需要快速有效的診斷。此外，精準醫療的廣泛應用，以及個人化醫療中對伴隨診斷指導患者治療策略的需求日益成長，將進一步推動市場成長。單株抗體廣泛應用於各種診斷方法，包括酵素連結免疫吸附試驗（ELISA）、流式細胞技術和生物標記檢測，其應用範圍不斷擴大，從而推動了市場成長。

然而，該市場面臨諸多限制因素，包括高昂的研發和檢驗成本以及嚴格的法規核准流程。儘管如此，對疾病早期檢測的強勁需求，加上癌症診斷支出的增加、多種生物標記檢測在更精準疾病診斷中的應用日益廣泛，以及伴隨檢測的普及，預計將為市場參與企業帶來巨大的商機。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究基於以下參數分析了全球癌症和非癌症診斷單株抗體市場的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份關於「用於癌症和非癌症診斷的單株抗體」的全球市場報告面向行業內的各種相關人員，包括經銷商、供應商、產品製造商、分銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球癌症和非癌症診斷用單株抗體市場時使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Abbott Laboratories
QIAGEN NV
Merck KGaA
Abcam plc
Sino Biological, Inc.

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9693

Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market is estimated to be valued at USD 10,129.3 Mn in 2026 and is expected to reach USD 18,291.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 10,129.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.80%	2033 Value Projection:	USD 18,291.2 Mn

The global monoclonal antibodies for cancer and non-cancer diagnostics market includes a diverse range of diagnostic products that are based on monoclonal antibodies. These antibody-based diagnostics are used to detect, distinguish, and manage a variety of diseases across different clinical indications, including oncology, infectious diseases, autoimmune diseases, and cardiovascular diseases. Due to their high levels of specificity and sensitivity, monoclonal antibodies find widespread use in several high-throughput techniques such as immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and companion diagnostics.

An increasing incidence of cancer, rising requirement for companion diagnostics and advancements in pathology and molecular diagnostic platforms are the key factors pushing the market's expansion. The expansion of monoclonal antibody applications in infectious disease diagnostics, the management of autoimmune disease and personalized therapy selection will continue to fuel adoption and cement monoclonal antibodies' status as crucial tools in the diagnostic arsenal across hospitals, diagnostic labs, and research organizations.

Market Dynamics

The global monoclonal antibodies for cancer and non-cancer diagnostics market is driven by the increasing number of chronic diseases that need prompt and effective diagnosis, such as cancer, autoimmune disorders, and infectious diseases. Furthermore, the expanding application of precision medicine coupled with a rising demand for companion diagnostics to guide patient treatments for personalized medicines will aid market expansion. Monoclonal antibodies are widely adopted in various diagnostic methods like ELISA, IHC, flow cytometry, and biomarker testing, resulting in augmented use and thus driving the market growth.

However, a number of constraints are present in the market, such as cost-intensive development and validation processes, as well as the need for thorough regulatory approvals. Nevertheless, robust demand for an earlier detection of the disease coupled with increased spending on cancer diagnostics, a growth in the use of multiplex biomarker tests for the precise diagnostics of the disease, and the increased uptake of companion tests are expected to provide lucrative opportunities for the market participants.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global monoclonal antibodies for cancer and non-cancer diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, QIAGEN N.V., Merck KGaA, Abcam plc, and Sino Biological, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global monoclonal antibodies for cancer and non-cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibodies for cancer and non-cancer diagnostics market

Market Segmentation

Antibody Type Insights (Revenue, USD Mn, 2021 - 2033)
Murine Antibodies
Rabbit Antibodies
Chimeric Antibodies
Humanized Antibodies
Fully Human Antibodies
Recombinant Antibodies
Others
Usage Techniques Insights (Revenue, USD Mn, 2021 - 2033)
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescent Immunoassay (CLIA)
Western Blot (WB)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Immunofluorescence (IF)
Lateral Flow Assay
Others
Application Insights (Revenue, USD Mn, 2021 - 2033)
Cancer
Obstetrics
Dengue
Chikungunya
Helicobacter pylori
Syphilis
HIV (Human immunodeficiency virus)
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
Clinical and Diagnostic Laboratories
Hospitals
Biopharmaceutical Companies
Research Institutions
Others
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
Offline
Online
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Abbott Laboratories
QIAGEN N.V.
Merck KGaA
Abcam plc
Sino Biological, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel
- Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Industry Trends

4. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Murine Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Rabbit Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Chimeric Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Humanized Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Fully Human Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Recombinant Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Chemiluminescent Immunoassay (CLIA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Western Blot (WB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Immunohistochemistry (IHC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Immunoprecipitation (IP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Immunofluorescence (IF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Lateral Flow Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Obstetrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Helicobacter pylori
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
HIV (Human immunodeficiency virus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Clinical and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abcam plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sino Biological, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies